10-Q: Healthcare AI Acquisition Corp. Faces Delisting and Liquidity Concerns Amidst Extended Business Combination Deadline

Healthcare AI Acquisition Corp. (HAIA) reported a net loss for Q1 2025, significant shareholder redemptions, and delisting from Nasdaq, while extending its business combination deadline with Leading Group Limited to October 2025.

Summary

• Healthcare AI Acquisition Corp. (HAIA) is a blank check company (SPAC) formed to effect a business combination, having entered into an agreement with Leading Group Limited, a digital insurance brokerage services provider in China, on August 15, 2024.
• The company reported a net loss of $74,119 for the three months ended March 31, 2025, compared to a net loss of $466,716 for the same period in 2024.
• Interest income from investments held in the Trust Account decreased significantly to $41,140 in Q1 2025 from $85,228 in Q1 2024, primarily due to substantial shareholder redemptions.
• The Trust Account balance stood at $4,758,369 as of March 31, 2025, down from an initial $219,936,490 following the IPO.
• Shareholder redemptions have been extensive, with 19,824,274 shares redeemed for $10.54 per share in June 2023, 1,146,276 shares for $10.73 per share in August 2023, 192,664 shares for $11.60 per share in November 2024, and an additional 246,676 shares tendered for redemption at approximately $11.95 per share in April 2025.
• HAIA's Class A ordinary shares were delisted from Nasdaq on December 17, 2024, due to non-compliance with the 36-month business combination deadline and now trade on the OTC Markets Pink Open Market.
• The deadline to complete a business combination has been repeatedly extended, most recently to October 14, 2025, on a month-to-month basis, requiring a deposit of $15,251.10 or $0.10 per non-redeemed public share for each monthly extension.
• The company has a working capital deficit of $1,405,550 as of March 31, 2025, and management has determined that its cash on hand is not sufficient to operate for the next 12 months, raising substantial doubt about its ability to continue as a going concern.
• Material weaknesses in internal control over financial reporting were identified, specifically in analyzing complex financial instruments (warrant liabilities) and recording accounts payable and accrued expenses.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to significant shareholder redemptions, delisting from Nasdaq, ongoing liquidity issues, and repeated extensions of the business combination deadline, all of which raise substantial doubt about the company's future viability and ability to complete its intended transaction.

Negatives

• The company reported a net loss of $74,119 for the three months ended March 31, 2025.
• Interest income from the Trust Account significantly decreased to $41,140 in Q1 2025 from $85,228 in Q1 2024, reflecting a substantial reduction in the Trust Account balance due to redemptions.
• The company has a working capital deficit of $1,405,550 as of March 31, 2025, indicating insufficient liquidity for ongoing operations.
• Extensive shareholder redemptions have drastically reduced the Trust Account balance from an initial $219,936,490 to $4,758,369 as of March 31, 2025, and approximately $4,772,246 after subsequent redemptions in April 2025.
• HAIA's securities were delisted from Nasdaq on December 17, 2024, due to failure to complete a business combination within the 36-month timeframe, leading to reduced liquidity and market visibility.
• The company identified material weaknesses in its internal control over financial reporting related to the valuation of warrant liabilities and the recording of accounts payable and accrued expenses.

Risks

• The company's ability to continue as a going concern is in substantial doubt due to insufficient cash outside the Trust Account to sustain operations for the next 12 months and the uncertainty of completing a business combination.
• Failure to complete the business combination by the extended deadline of October 14, 2025, will result in mandatory liquidation and dissolution, leading to the expiration of warrants worthlessly.
• Delisting from Nasdaq to the OTC Markets Group Pink Open Market may adversely affect the liquidity and trading of the company's securities, making it less attractive for investors and potential merger partners.
• The company's Class A ordinary shares are now deemed a 'penny stock' under SEC Rule 419, subjecting brokers to more stringent rules and potentially further reducing trading activity.
• The listing of the post-Business Combination combined company's securities on Nasdaq is a condition precedent to closing the Business Combination, which may be challenging to meet given the current delisted status and potential difficulties in satisfying Nasdaq's listing requirements (e.g., minimum bid price, market value of publicly held shares).
• The business combination with Leading Group Limited, a provider of insurance products in the People's Republic of China, may be subject to U.S. foreign investment regulations and review by entities like CFIUS, which could block or delay the transaction.
• Geopolitical instability from ongoing conflicts (Russia-Ukraine, Israel-Hamas) could lead to market disruptions, volatility in commodity prices, credit and capital markets, supply chain interruptions, and increased cyber-attacks, potentially impacting the company's operations and financial markets.

Future Outlook

The company's future outlook is highly uncertain, with management expressing substantial doubt about its ability to continue as a going concern. The primary focus remains on consummating the business combination with Leading Group Limited by the extended deadline of October 14, 2025. Failure to do so will result in mandatory liquidation. The company anticipates that its current cash on hand is insufficient for the next 12 months and may need to raise additional capital through working capital loans or promissory notes, though there is no assurance new financing will be available on acceptable terms.

Management Comments

• Management has determined that mandatory liquidation, and subsequent dissolution, should the Company be unable to complete a business combination, raises substantial doubt about the Company's ability to continue as a going concern for the next twelve months from the issuance of these financial statements.
• The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.

Industry Context

Healthcare AI Acquisition Corp. operates as a Special Purpose Acquisition Company (SPAC), a vehicle designed to raise capital through an IPO to acquire an existing private company. The SPAC market has experienced significant volatility and increased regulatory scrutiny, particularly regarding de-SPAC transactions and deadlines. HAIA's situation, marked by substantial redemptions, repeated deadline extensions, and delisting from Nasdaq, reflects broader challenges faced by SPACs struggling to identify and close suitable business combinations within their mandated timelines. The target, Leading Group Limited, is in digital insurance brokerage services in China, indicating a cross-border transaction that adds complexity and potential regulatory hurdles, such as CFIUS review, which is a growing concern for U.S.-listed entities with foreign ties.

Comparison to Industry Standards

• **Trust Account Erosion:** HAIA's Trust Account balance has been severely depleted from an initial $219.9 million to approximately $4.7 million, representing a redemption rate far exceeding typical SPAC averages, which often see 50-70% redemptions but rarely near 98%. This level of redemptions is significantly worse than industry standards and indicates a strong lack of investor confidence in the proposed business combination or the SPAC's ability to execute.
• **Delisting from Major Exchange:** The delisting from Nasdaq to the OTC Pink Market is a critical negative deviation from industry standards. SPACs typically aim for a Nasdaq or NYSE listing for their combined entity, as it provides greater liquidity, visibility, and institutional investor access. Trading on the OTC Pink Market is associated with lower liquidity, less transparency, and often a 'penny stock' designation, making the company less attractive compared to peers that maintain major exchange listings.
• **Extended Combination Period:** While SPACs often seek extensions, HAIA's multiple extensions (from 18 months to June 2024, then December 2024, then June 2025, and now October 2025) and the associated costs (monthly deposits into the trust account) are indicative of significant difficulties in closing a deal. Successful SPACs typically complete their combinations within the initial 18-24 month period or with a single, well-defined extension.
• **Liquidity and Going Concern:** The reported working capital deficit of $1.4 million and management's 'substantial doubt' about going concern are severe red flags. Healthy SPACs maintain sufficient working capital to cover operational expenses and due diligence without relying heavily on related-party loans or facing imminent liquidity crises, especially before a business combination is finalized.
• **Internal Control Weaknesses:** The disclosure of material weaknesses in internal controls, particularly concerning complex financial instruments like warrants, is a governance concern. While not uncommon, it suggests a lack of robust financial oversight compared to best practices for public companies, even SPACs.

Management Changes

Corporate Governance

Related Party Transactions

• The New Sponsor loaned the Company a total of $100,000 in June and July 2023 via a non-interest bearing, unsecured promissory note due upon closing of an initial Business Combination.
• From July to December 2023, the New Sponsor and its shareholder loaned an additional $51,449 and $65,000, respectively, under similar promissory notes.
• On August 23, 2024, the Company issued an unsecured promissory note for $350,000 to LEADING for working capital.
• On November 21, 2024, another unsecured promissory note for $100,000 was issued to LEADING for working capital.
• On January 13, 2025, a non-interest bearing, unsecured promissory note for $52,692 was issued to LEADING for an extension payment.
• On January 17, 2025, an unsecured promissory note for $100,000 was issued to LEADING for working capital.
• As of March 31, 2025, total borrowings under promissory notes from related parties amounted to $828,625.
• The Company had $447,174 in borrowings under Working Capital Loans from the New Sponsor as of March 31, 2025.
• The Former Sponsor waived entitlement to $177,095 in administrative service fees and $347,285 in deferred legal expenses upon Sponsor Handover, treated as capital contributions.

Stakeholder Impact

• **Shareholders:** Public shareholders have experienced significant dilution and loss of value through extensive redemptions and the delisting of shares from Nasdaq, leading to reduced liquidity and a 'penny stock' designation. Those who remain face substantial risk of losing their investment if the business combination is not completed by October 2025.
• **Sponsor/Related Parties:** The New Sponsor and Leading Group Limited have provided significant loans and promissory notes to fund extensions and working capital, indicating their continued financial commitment but also exposure to the company's going concern risks.
• **Creditors:** In the event of liquidation, creditors' claims could have priority over public shareholders, potentially leading to no recovery for shareholders.
• **Employees:** As a blank check company, there is no direct impact on a large employee base, but the uncertainty affects management and directors involved in the SPAC's operations.

Next Steps

• Complete the business combination with Leading Group Limited by the extended deadline of October 14, 2025.
• Address the identified material weaknesses in internal control over financial reporting.
• Potentially raise additional capital through working capital loans or promissory notes to sustain operations.

Key Dates

Recommendation

Keywords

SPAC, Healthcare AI Acquisition Corp, HAIA, Leading Group Limited, Business Combination, SEC filing, 10-Q, Delisting, Nasdaq, OTC Markets, Shareholder Redemptions, Trust Account, Warrants, Going Concern, Financial Reporting, Internal Controls, China Insurance, Special Purpose Acquisition Company